Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Phathom Pharmaceuticals, Inc. - Common Stock (NQ:PHAT)

2.760 -0.600 (-17.86%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,704,864
Open 3.380
Bid (Size) 2.800 (32)
Ask (Size) 2.820 (2)
Prev. Close 3.360
Today's Range 2.710 - 3.395
52wk Range 2.710 - 19.71
Shares Outstanding 43,614,075
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Retail Interest in Phathom Soars As Firm Pledges Profit Path, Cuts Costs After Q1 Miss
Phathom's VOQUEZNA prescriptions rose 8% sequentially in Q1, with over 390,000 cumulative fills and expanding adoption across both GI and primary care. 
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Here are the top movers in Thursday's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill

Performance

YTD
-62.3%
-62.3%
1 Month
-44.9%
-44.9%
3 Month
-51.0%
-51.0%
6 Month
-85.4%
-85.4%
1 Year
-72.5%
-72.5%

More News

Read More
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Phathom Pharmaceuticals
Via GlobeNewswire
Earnings Scheduled For May 1, 2025
Via Benzinga
Top stock movements in today's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Thursday's session.
Via Chartmill
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
From Phathom Pharmaceuticals
Via GlobeNewswire
Insights Ahead: Phathom Pharmaceuticals's Quarterly Earnings
Via Benzinga
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting
From Phathom Pharmaceuticals
Via GlobeNewswire
Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025
From Phathom Pharmaceuticals
Via GlobeNewswire
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
From Phathom Pharmaceuticals
Via GlobeNewswire
Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
From Phathom Pharmaceuticals
Via GlobeNewswire
Top movers in Tuesday's session
Via Chartmill
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Phathom Pharmaceuticals
Via GlobeNewswire
Phathom Pharmaceuticals Announces Leadership Succession
From Phathom Pharmaceuticals
Via GlobeNewswire
Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)
From Phathom Pharmaceuticals
Via GlobeNewswire
Traders are paying attention to the gapping stocks in Tuesday's session.
Via Chartmill
IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From Phathom Pharmaceuticals
Via GlobeNewswire
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025
From Phathom Pharmaceuticals
Via GlobeNewswire
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
From Phathom Pharmaceuticals
Via GlobeNewswire
Earnings Scheduled For March 6, 2025
Via Benzinga
Top Biotech Short Squeeze Stocks
Via Talk Markets
Topics Stocks / Equities
Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets
From Phathom Pharmaceuticals
Via GlobeNewswire

Frequently Asked Questions

Is Phathom Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Phathom Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Phathom Pharmaceuticals, Inc. - Common Stock trade on?
Phathom Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Phathom Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Phathom Pharmaceuticals, Inc. - Common Stock is PHAT on the Nasdaq Stock Market
What is the current price of Phathom Pharmaceuticals, Inc. - Common Stock?
The current price of Phathom Pharmaceuticals, Inc. - Common Stock is 2.760
When was Phathom Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Phathom Pharmaceuticals, Inc. - Common Stock was at 05/02/25 04:00 PM ET
What is the market capitalization of Phathom Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Phathom Pharmaceuticals, Inc. - Common Stock is 120.37M
How many shares of Phathom Pharmaceuticals, Inc. - Common Stock are outstanding?
Phathom Pharmaceuticals, Inc. - Common Stock has 120M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.